Re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011.

Zhao, Binghao; Wu, Jiaming; Zhang, Ruidong

doi:10.1016/j.eururo.2023.03.040

%0 Journal Article
%A Zhao, Binghao
%A Zhang, Ruidong
%A Wu, Jiaming
%T Re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011.
%J European urology
%V 84
%N 1
%@ 0302-2838
%C Amsterdam [u.a.]
%I Elsevier Science
%M DKFZ-2023-00858
%P e20-e21
%D 2023
%Z #EA:D170# / 2023 Jul;84(1):e20-e21
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37121849
%R 10.1016/j.eururo.2023.03.040
%U https://inrepo02.dkfz.de/record/275759

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help